BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 37158349)

  • 1. Diagnosis of Mycosis Fungoides after Dupilumab Treatment for Atopic Dermatitis.
    O'Neill L; Duffy RF; Manders SM
    Skinmed; 2023; 21(2):105-106. PubMed ID: 37158349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mycosis Fungoides Unmasked by Dupilumab Treatment in a Patient With a History of Atopic Dermatitis.
    Ayasse M; Nelson K; Glass F; Silverberg JI
    Dermatitis; 2021 Oct; 32(1S):e88-e89. PubMed ID: 33273230
    [No Abstract]   [Full Text] [Related]  

  • 3. Unmasking a masquerader: Mycosis fungoides unveiled after dupilumab treatment.
    Joshi TP; Duvic M
    J Am Acad Dermatol; 2023 Jun; 88(6):e305-e306. PubMed ID: 36858155
    [No Abstract]   [Full Text] [Related]  

  • 4. Dupilumab, Atopic Dermatitis, and Mycosis Fungoides-New Insights on an Evolving Story.
    Guitart J
    JAMA Dermatol; 2023 Nov; 159(11):1177-1178. PubMed ID: 37851433
    [No Abstract]   [Full Text] [Related]  

  • 5. Diagnosis of Mycosis Fungoides Following Administration of Dupilumab for Misdiagnosed Atopic Dermatitis.
    Chiba T; Nagai T; Osada SI; Manabe M
    Acta Derm Venereol; 2019 Jul; 99(9):818-819. PubMed ID: 31045233
    [No Abstract]   [Full Text] [Related]  

  • 6. Diagnosis of mycosis fungoides or Sézary syndrome after dupilumab use: A systematic review.
    Jfri A; Smith JS; Larocca C
    J Am Acad Dermatol; 2023 May; 88(5):1164-1166. PubMed ID: 36481378
    [No Abstract]   [Full Text] [Related]  

  • 7. Dupilumab-associated mycosis fungoides: a cross-sectional study.
    Hamp A; Hanson J; Schwartz RA; Lambert WC; Alhatem A
    Arch Dermatol Res; 2023 Nov; 315(9):2561-2569. PubMed ID: 37270763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two cases of mycosis fungoides diagnosed after treatment non-response to dupilumab.
    Newsom M; Hrin ML; Hamid RN; Strowd LC; Ahn C; Jorizzo JL; Feldman SR
    Dermatol Online J; 2021 Jan; 27(1):. PubMed ID: 33560800
    [No Abstract]   [Full Text] [Related]  

  • 9. Evolution of Dupilumab-Associated Cutaneous Atypical Lymphoid Infiltrates.
    Sokumbi O; Shamim H; Davis MDP; Wetter DA; Newman CC; Comfere N
    Am J Dermatopathol; 2021 Oct; 43(10):714-720. PubMed ID: 34132660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of refractory conjunctivitis associated to dupilumab with topical pimecrolimus applied to the eyelid skin.
    Sernicola A; Gattazzo I; Di Staso F; Giordano D; Capalbo A; Persechino F; Scuderi G; Persechino S
    Dermatol Ther; 2019 Nov; 32(6):e13134. PubMed ID: 31639238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid resolution of diffuse warts following initiation of dupilumab for severe atopic dermatitis.
    Netravali IA; Sockler PG; Heimall J; Treat JR
    Pediatr Dermatol; 2024; 41(2):275-278. PubMed ID: 37680146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dupilumab Provides Acceptable Safety and Sustained Efficacy for up to 4 Years in an Open-Label Study of Adults with Moderate-to-Severe Atopic Dermatitis.
    Beck LA; Deleuran M; Bissonnette R; de Bruin-Weller M; Galus R; Nakahara T; Seo SJ; Khokhar FA; Vakil J; Xiao J; Marco AR; Levit NA; O'Malley JT; Shabbir A
    Am J Clin Dermatol; 2022 May; 23(3):393-408. PubMed ID: 35503163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Folliculotropic mycosis fungoides].
    Baratli J; Balakirski G; Megahed M
    Hautarzt; 2014 Dec; 65(12):1011-3. PubMed ID: 25355498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe atopic dermatitis: Dupilumab is not just safer, but more efficient.
    Giavina-Bianchi M; Rizzo LV; Giavina-Bianchi P
    Allergol Immunopathol (Madr); 2020; 48(6):792-797. PubMed ID: 32249095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dupilumab Versus Cyclosporine for the Treatment of Moderate-to-Severe Atopic Dermatitis in Adults: Indirect Comparison Using the Eczema Area and Severity Index.
    Ariëns LFM; Gadkari A; van Os-Medendorp H; Ayyagari R; Terasawa E; Kuznik A; Chen Z; Bégo-Le Bagousse G; Lu Y; Rizova E; Graham NMH; Pirozzi G; De Bruin-Weller M; Eckert L
    Acta Derm Venereol; 2019 Sep; 99(10):851-857. PubMed ID: 31099402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-Term Efficacy and Safety of Dupilumab in Adolescents with Moderate-to-Severe Atopic Dermatitis: Results Through Week 52 from a Phase III Open-Label Extension Trial (LIBERTY AD PED-OLE).
    Blauvelt A; Guttman-Yassky E; Paller AS; Simpson EL; Cork MJ; Weisman J; Browning J; Soong W; Sun X; Chen Z; Kosloski MP; Kamal MA; Delevry D; Chuang CC; O'Malley JT; Bansal A
    Am J Clin Dermatol; 2022 May; 23(3):365-383. PubMed ID: 35567671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of dupilumab with concomitant topical corticosteroids in children 6 to 11 years old with severe atopic dermatitis: A randomized, double-blinded, placebo-controlled phase 3 trial.
    Paller AS; Siegfried EC; Thaçi D; Wollenberg A; Cork MJ; Arkwright PD; Gooderham M; Beck LA; Boguniewicz M; Sher L; Weisman J; O'Malley JT; Patel N; Hardin M; Graham NMH; Ruddy M; Sun X; Davis JD; Kamal MA; Khokhar FA; Weinreich DM; Yancopoulos GD; Beazley B; Bansal A; Shumel B
    J Am Acad Dermatol; 2020 Nov; 83(5):1282-1293. PubMed ID: 32574587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dupilumab-Associated Conjunctivitis in Patients With Atopic Dermatitis.
    Liberman P; Shifera AS; Berkenstock M
    Cornea; 2020 Jun; 39(6):784-786. PubMed ID: 31985517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conjunctivitis in Dupilumab Clinical Trials for Adolescents with Atopic Dermatitis or Asthma.
    Bansal A; Simpson EL; Paller AS; Siegfried EC; Blauvelt A; de Bruin-Weller M; Corren J; Sher L; Guttman-Yassky E; Chen Z; Daizadeh N; Kamal MA; Shumel B; Mina-Osorio P; Mannent L; Patel N; Graham NMH; Khokhar FA; Ardeleanu M
    Am J Clin Dermatol; 2021 Jan; 22(1):101-115. PubMed ID: 33481203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness and safety of tacrolimus ointment combined with dupilumab for patients with atopic dermatitis in real-world clinical practice.
    Matsutani M; Imai Y; Inoue Y; Nakatani-Kusakabe M; Natsuaki M; Yamanishi K; Kanazawa N
    J Dermatol; 2021 Oct; 48(10):1564-1568. PubMed ID: 34155694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.